FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2625782391> ?p ?o ?g. }

• W2625782391 abstract "Treatment in metastatic colorectal cancer (mCRC) has expanded with monoclonal antibodies targeting epidermal growth factor receptor, but is restricted to patients with a wild-type (WT) KRAS mutational status. The most sensitive assays for KRAS mutation detection in formalin-fixed paraffin embedded (FFPE) tissues are based on real-time PCR. Among them, high resolution melting analysis (HRMA), is a simple, fast, highly sensitive, specific and cost-effective method, proposed as adjunct for KRAS mutation detection. However the method to categorize WT vs mutant sequences in HRMA is not clearly specified in available studies, besides the impact of FFPE artifacts on HRMA performance hasn't been addressed either.Avowedly adequate samples from 104 consecutive mCRC patients were tested for KRAS mutations by Therascreen™ (FDA Validated test), HRMA, and HRMA with UDG pre-treatment to reverse FFPE fixation artifacts. Comparisons of KRAS status allocation among the three methods were done. Focusing on HRMA as screening test, ROC curve analyses were performed for HRMA and HMRA-UDG against Therascreen™, in order to evaluate their discriminative power and to determine the threshold of profile concordance between WT control and sample for KRAS status determination.Comparing HRMA and HRMA-UDG against Therascreen™ as surrogate gold standard, sensitivity was 1 for both HRMA and HRMA-UDG; and specificity and positive predictive values were respectively 0.838 and 0.939; and 0.777 and 0.913. As evaluated by the McNemar test, HRMA-UDG allocated samples to a WT/mutated genotype in a significatively different way from HRMA (p > 0.001). On the other hand HRMA-UDG did not differ from Therascreen™ (p = 0.125). ROC-curve analysis showed a significant discriminative power for both HRMA and HRMA-UDG against Therascreen™ (respectively, AUC of 0.978, p > 0.0001, CI 95% 0.957-0.999; and AUC of 0.98, p > 0.0001, CI 95% 0.000-1.0). For HRMA as a screening tool, the best threshold (degree of concordance between sample curves and WT control) was attained at 92.14% for HRMA (specificity of 0.887), and at 92.55% for HRMA-UDG (specificity of 0.952).HRMA is a highly sensitive method for KRAS mutation detection, with apparently adequate and statistically significant discriminative power. FFPE sample fixation artifacts have an impact on HRMA results, so for HRMA on FFPE samples pre-treatment with UDG should be strongly suggested. The choice of the threshold for melting curve concordance has also great impact on HRMA performance. A threshold of 93% or greater might be adequate if using HRMA as a screening tool. Further validation of this threshold is required." @default.
• W2625782391 created "2017-06-23" @default.
• W2625782391 creator A5007157180 @default.
• W2625782391 creator A5010495838 @default.
• W2625782391 creator A5017032210 @default.
• W2625782391 creator A5022488513 @default.
• W2625782391 creator A5027650674 @default.
• W2625782391 creator A5085910142 @default.
• W2625782391 date "2017-10-01" @default.
• W2625782391 modified "2023-10-18" @default.
• W2625782391 title "Impact of fixation artifacts and threshold selection on high resolution melting analysis for KRAS mutation screening" @default.
• W2625782391 cites W1566278414 @default.
• W2625782391 cites W1621419473 @default.
• W2625782391 cites W1757407923 @default.
• W2625782391 cites W1842190671 @default.
• W2625782391 cites W1991935700 @default.
• W2625782391 cites W1993722964 @default.
• W2625782391 cites W2003246614 @default.
• W2625782391 cites W2020094108 @default.
• W2625782391 cites W2022561510 @default.
• W2625782391 cites W2038624343 @default.
• W2625782391 cites W2044327435 @default.
• W2625782391 cites W2062389942 @default.
• W2625782391 cites W2085793842 @default.
• W2625782391 cites W2095201384 @default.
• W2625782391 cites W2097943106 @default.
• W2625782391 cites W2110389586 @default.
• W2625782391 cites W2130611671 @default.
• W2625782391 cites W2135184154 @default.
• W2625782391 cites W2144425748 @default.
• W2625782391 cites W2146775979 @default.
• W2625782391 cites W2148253728 @default.
• W2625782391 cites W2154448561 @default.
• W2625782391 cites W2155893084 @default.
• W2625782391 cites W2160577249 @default.
• W2625782391 cites W2162105023 @default.
• W2625782391 cites W2163195607 @default.
• W2625782391 cites W2168428430 @default.
• W2625782391 cites W2169034512 @default.
• W2625782391 cites W2170545088 @default.
• W2625782391 cites W2176041446 @default.
• W2625782391 cites W2316084265 @default.
• W2625782391 cites W2406227129 @default.
• W2625782391 cites W2416326407 @default.
• W2625782391 cites W2498621056 @default.
• W2625782391 cites W2574817140 @default.
• W2625782391 doi "https://doi.org/10.1016/j.mcp.2017.06.003" @default.
• W2625782391 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28627450" @default.
• W2625782391 hasPublicationYear "2017" @default.
• W2625782391 type Work @default.
• W2625782391 sameAs 2625782391 @default.
• W2625782391 citedByCount "2" @default.
• W2625782391 countsByYear W26257823912018 @default.
• W2625782391 countsByYear W26257823912021 @default.
• W2625782391 crossrefType "journal-article" @default.
• W2625782391 hasAuthorship W2625782391A5007157180 @default.
• W2625782391 hasAuthorship W2625782391A5010495838 @default.
• W2625782391 hasAuthorship W2625782391A5017032210 @default.
• W2625782391 hasAuthorship W2625782391A5022488513 @default.
• W2625782391 hasAuthorship W2625782391A5027650674 @default.
• W2625782391 hasAuthorship W2625782391A5085910142 @default.
• W2625782391 hasConcept C104317684 @default.
• W2625782391 hasConcept C121608353 @default.
• W2625782391 hasConcept C135763542 @default.
• W2625782391 hasConcept C2778332735 @default.
• W2625782391 hasConcept C2779998722 @default.
• W2625782391 hasConcept C2781187634 @default.
• W2625782391 hasConcept C34372108 @default.
• W2625782391 hasConcept C526805850 @default.
• W2625782391 hasConcept C54355233 @default.
• W2625782391 hasConcept C86803240 @default.
• W2625782391 hasConceptScore W2625782391C104317684 @default.
• W2625782391 hasConceptScore W2625782391C121608353 @default.
• W2625782391 hasConceptScore W2625782391C135763542 @default.
• W2625782391 hasConceptScore W2625782391C2778332735 @default.
• W2625782391 hasConceptScore W2625782391C2779998722 @default.
• W2625782391 hasConceptScore W2625782391C2781187634 @default.
• W2625782391 hasConceptScore W2625782391C34372108 @default.
• W2625782391 hasConceptScore W2625782391C526805850 @default.
• W2625782391 hasConceptScore W2625782391C54355233 @default.
• W2625782391 hasConceptScore W2625782391C86803240 @default.
• W2625782391 hasFunder F4320321739 @default.
• W2625782391 hasLocation W26257823911 @default.
• W2625782391 hasLocation W26257823912 @default.
• W2625782391 hasOpenAccess W2625782391 @default.
• W2625782391 hasPrimaryLocation W26257823911 @default.
• W2625782391 hasRelatedWork W1972181518 @default.
• W2625782391 hasRelatedWork W2038386885 @default.
• W2625782391 hasRelatedWork W2066082532 @default.
• W2625782391 hasRelatedWork W2096595178 @default.
• W2625782391 hasRelatedWork W2106330098 @default.
• W2625782391 hasRelatedWork W2116448148 @default.
• W2625782391 hasRelatedWork W2171311886 @default.
• W2625782391 hasRelatedWork W2204796656 @default.
• W2625782391 hasRelatedWork W2589642515 @default.
• W2625782391 hasRelatedWork W2589962045 @default.
• W2625782391 isParatext "false" @default.
• W2625782391 isRetracted "false" @default.
• W2625782391 magId "2625782391" @default.
• W2625782391 workType "article" @default.